Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Ehave Appoints Board-Certified Gastroenterologist And Licensed Physician Dr. Rahul Dixit To Its Medical Advisory Board

Published

on

MIAMI, Sept. 21, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today Dr. Rahul Dixit has agreed to join the Company’s Medical Advisory Board. As a member of Ehave’s Medical Advisory Board, Dr. Dixit’s primary responsibilities will be to assist and advise the Company on human trials for its cognitive and psychedelic opportunities, as well as assist and advise the Company on mental health analytical platforms.

Rahul Dixit, MD Dr. Rahul Dixit, MD is a Gastroenterology Specialist with over 17 years of experience in the medical field. He graduated from the University of Maryland School of Medicine; he completed his residency in Internal Medicine, and a double fellowship in Gastroenterology, at the University of Miami and Hepatology/Liver Transplant at Johns Hopkins Hospital.

As a student, Rahul Dixit accumulated numerous honors, including the Distinguished Medical Student Service Award. He graduated in the top 1 percent of his undergraduate class and received the Phi Beta Kappa Award. Thanks to his outstanding academic achievements, he is one of the most sought out providers in the medical field.

Dr. Dixit is certified by the American Board of Internal Medicine in both Gastroenterology and Internal Medicine. He has been widely published in numerous medical journals. Recently, Dr. Dixit was awarded “Top Doc” in LA Magazine 2020.

For the past decade, Dr. Dixit has accelerated his business interests as an avid angel investor in biotech pharma and health supplement space. He is a healthcare advisor for many companies including BirlaDK Capital Advisors, G-Plans, Uniquely You, and DNA Analytical Services. He also co-founded Manas Ventures, a highly successful herbal and cannabis focused Biotech venture fund. Dr. Dixit has continued to research and write papers that not only improve his skills and ability to treat patients but, also, adds to the information available to gastroenterologists around the world.

Dr. Rahul Dixit said, “I’m very excited to be a part of Ehave and add to what they have quickly and greatly accomplished in such short time. We know that the gastrointestinal (GI) tract and gut has its own nervous system called the enteric system which is made up of trillions of organisms.” Dr. Dixit continued, “Anywhere from 10-15% of the worldwide population suffers from irritable bowel syndrome (IBS) as well as other functional diseases which are significantly affected by underlying mental health diseases like depression. I’m looking forward to helping patients all around the world with Ehave get closer to understanding the positive effects psychedelic compounds could have on their gastrointestinal ailments and overall health.”

Ben Kaplan, CEO of Ehave, Inc. said, “Ehave is very fortunate to include such an esteemed medical professional as Dr. Dixit as a member of our Medical Advisory Board. His credentials and experience make him a perfect fit for Ehave. We look forward to Dr. Dixit’s expert as we expand our mental health analytical platform and enter clinical trials.”

About Ehave, Inc.

Ehave, Inc. is a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients. Our primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, psychedelics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes meeting privacy and HIPAA & GDPR Compliant. Our main product is the Ehave Dashboard which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using Blockchain technology. The Ehave dashboard offers Offline Encrypted Digital Records Empowering Healthcare providers and patients and it’s a powerful machine learning and artificial intelligence platform using artificial intelligence to extract deep insights from audio, video and text to improve research with a growing set of advanced tools and applications developed by Ehave and its leading partners. This empowers patients, healthcare providers, and payers to address a wide range of conditions through high quality, safe, and effective data-driven involvement with intelligent and accessible tools.

Forward-Looking Statement Disclaimer

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is contained under the heading “Risk Factors” in Ehave, Inc.’s Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC) on September 24, 2015, as amended, which is available on the SEC’s website, http://www.sec.gov.

For Investors Relations, please contact:

Gabe Rodriguez

Phone: (623) 261-9046

Email: [email protected]

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Addverb Releases 2023 Sustainability Report Detailing Company’s Journey towards Technological Ecology

Published

on

addverb-releases-2023-sustainability-report-detailing-company’s-journey-towards-technological-ecology

Successfully achieving the FY22-23 Extended Producer Responsibility (EPR) target of 3 metric tonnesFulfilled 17% of energy demand from renewable sources in CY 2023Improvement of the power factor from 0.88 to 0.99 over two yearsNOIDA, India, April 30, 2024 /PRNewswire/ — Addverb, a global leader in robotics and automation, releases its first Sustainability Report titled ‘Technological Ecology’. The report is produced in accordance with GRI Universal Standards and incorporates Environment, Social, and Governance (ESG) factors underscoring Addverb’s unwavering dedication to sustainability and commitment. Reporting initiatives from January 1st to December 3st, 2023, the report showcases Addverb’s commitment to Technological Ecology, aiming to reduce ecological impact while contributing to the planet’s well-being.

The report can be accessed on the Company’s website.
Commenting on the release of the report, Mr. Sangeet Kumar, Co-founder and CEO, Addverb said, “Addverb harnesses solar energy, employs energy-efficient machinery, and integrates lean manufacturing practices to reduce Greenhouse gas (GHG) emissions and promote responsible power consumption. Our vision extends beyond product creation to embedding sustainability throughout our designs and manufacturing processes, focusing on ecological balance and technological advancements.”
Addverb is committed to mitigating environmental impact through proactive measures and innovation, including strategic tree-planting initiatives, green belt cultivation for ecological restoration, sustainable water management practices with a focus on groundwater recharge, and fostering an inclusive workplace environment through Diversity, Equity, and Inclusion (DEI) initiatives.
Addverb, through this report, reflects its unwavering dedication to sustainability, innovation, and responsible business practices. By prioritising environmental stewardship and social responsibility, the company continues to pave the way for a greener and a more sustainable future.
About Addverb
Founded in 2016, Addverb offers end-to-end robotics solutions for warehouses and industrial automation. Addverb is based in India, with R&D facilities in India and the US, and subsidiaries worldwide, including Australia, Singapore, the Netherlands, and the US. Its fleet of automated robots and material handling technologies, along with in-house system integration and software solutions, enhances warehouse operations’ efficiency and accuracy.
Addverb provides tailored automation solutions, with its self-manufactured products, and a wide range portfolio consisting of Autonomous Mobile Robots, Sorting Robots, Automated Storage and Retrieval Systems, and Picking Technologies, fuelled by enterprise software; with a range of 350+ customers like Coca-Cola, PepsiCo, Unilever, Reliance, DHL, Amazon, ITC to name a few.
For more information visit: www.addverb.com or connect on [email protected].  
Photo : https://mma.prnewswire.com/media/2399932/Bioretention_pond.jpg Logo : https://mma.prnewswire.com/media/2399931/Addverb_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/addverb-releases-2023-sustainability-report-detailing-companys-journey-towards-technological-ecology-302130075.html

Continue Reading

Artificial Intelligence

New Independent Study Shows 70% of Organizations Prioritize Gen AI for Boosting Employee Productivity

Published

on

new-independent-study-shows-70%-of-organizations-prioritize-gen-ai-for-boosting-employee-productivity

The exclusive study commissioned by Apexon reveals how organizations, particularly from more regulated industries, are seizing the GenAI advantageOver 50% of surveyed organizations are implementing Gen AI in their businessesSUNDERLAND, England, April 30, 2024 /PRNewswire/ —  Apexon, a digital-first technology services company, today unveiled key findings from a Forrester Opportunity Snapshot Study “Regulated Industries Are Making Generative AI Core to Their Digital Strategy.” The study commissioned by Apexon and conducted by Forrester Consulting highlights significant insights into the adoption, challenges, and future of Gen AI in highly regulated industries such as Financial Services, Healthcare and Life Sciences. A critical finding is that while organizational readiness may not impede Gen AI adoption, the absence of governance proves to be a significant barrier.

 
 
The study surveyed 125 US-based CXOs and key decision-makers responsible for AI strategy, representing organizations.
According to the findings, a significant 71% of organizations prefer to procure Gen AI solutions from technology vendors, underscoring the strategic shift towards leveraging external expertise for technological advancement. The findings also throw light on the transformative potential of Gen AI to enhance employee productivity and customer experience.
Key highlights from the study also include:
Enhancing employee productivity has emerged as the primary use case surpassing customer experience, traditionally the most prevalent industry use case. 70% of the surveyed organizations are directing their investments in Generative AI towards elevating employee efficiency for more impactful activities.Investments in building a strong Gen AI ecosystem are expected to increase significantly in 2025.Financial Services prioritize customer service improvements, while Healthcare Life Sciences focus on digital operations enhancement with Gen AI. “Generative AI is arguably the most disruptive technology, set to revolutionize industries and redefine work paradigms,” said Sriniketh Chakravarthi, Chief Executive Officer, Apexon. “This study has unearthed crucial insights for regulated industries aiming to harness Gen AI’s true potential. The findings underscore the importance of an effective AI governance program, a human-in-the-loop approach to manage accuracy risks and the pivot employees will make from routine to more strategic and creative elements of their work.”
Apexon’s Gen AI capabilities:
Specializing in customized Gen AI solutions, Apexon addresses unique organizational needs and industry challenges by leveraging deep industry domain knowledge and advanced AI/ML expertise to design contextualized, human-centric applications that drive real-world outcomes. Genysys, a proprietary platform by Apexon, combines over 10+ LLM models into a versatile platform, streamlining content creation and workflow while ensuring fast processing and minimal latency. It unlocks Generative AI’s full potential for innovative, tailored content, enhancing operational efficiency and engagement. 
Click here to download the full study, titled “Regulated Industries Are Making Generative AI Core to Their Digital Strategy,” and discover more insights.
About Apexon:
Apexon is a digital-first technology services firm specializing in accelerating business transformation and delivering human-centric digital experiences. For over 17 years, the company has been meeting clients wherever they are in the digital lifecycle and helping them outperform their competition through speed and innovation. Its reputation is built on a comprehensive suite of engineering services, a dedication to solving clients’ toughest technology problems, and a commitment to continuous improvement. The company focuses on three broad solution areas of digital services: Digital Experience, Data Services, and Digital Engineering and has deep expertise in BFSI, healthcare, and life sciences. Apexon is backed by Goldman Sachs Asset Management and Everstone Capital.
Learn how Apexon helps clients with their digital transformation journeys at www.apexon.com.
Logo: https://mma.prnewswire.com/media/2263554/4375910/Apexon_Logo.jpg
Media contact:[email protected] 

View original content:https://www.prnewswire.co.uk/news-releases/new-independent-study-shows-70-of-organizations-prioritize-gen-ai-for-boosting-employee-productivity-302130442.html

Continue Reading

Artificial Intelligence

Droit and FINBOURNE Partner to Deliver End-to-End Position Reporting Solution

Published

on

droit-and-finbourne-partner-to-deliver-end-to-end-position-reporting-solution

LONDON, April 30, 2024 /PRNewswire/ — Droit, a technology firm at the forefront of computational law and regulation, will partner with FINBOURNE Technology, a provider of cloud-based investment data management software, to launch an end-to-end position reporting solution for increased regulatory transparency.

Over one hundred global jurisdictions have position reporting obligations, requiring market participants to report equity and equity derivatives holdings to regulatory bodies; a process that is complex, time consuming and costly.
Droit and FINBOURNE come together to deliver a joint, full-stack solution to enable sell-side and buy-side institutions to manage disclosure obligations for long, short and takeover panel reporting. This new offering leverages FINBOURNE’s financial data management platform LUSID, embedded with Droit’s Position Reporting product which delivers clear determination of reporting obligations based on consensus interpretations of requirements from Endoxa, a consortium of six global financial institutions. 
The unified approach ensures consistency around complex regulatory interpretations, regulatory clarity and accuracy of reporting. As part of the joint solution, Droit translates and processes detailed guidelines from all major global jurisdictions, automating the decision-making process for shareholder disclosure reporting eligibility. For complete accountability, a traceable audit record is generated for each evaluated position.
With FINBOURNE’s advanced data transformation capabilities, the new end-to-end solution seamlessly maps the multiple data inputs needed to evaluate rules. Moreover, it simplifies workflow interactions via an intuitive interface, effectively mitigating operational, cost, and complexity challenges.
“Integrating Droit into LUSID means that together we are able to deliver a complete solution for position reporting. This partnership enhances our ability to safeguard asset managers by making sense of shareholder disclosure data when it comes to complex trading books and provide a level of granular reporting detail that is unmatched in the industry.” added Thomas McHugh, CEO and Co-founder, FINBOURNE Technology.
“By partnering with FINBOURNE, we are able to leverage consensus interpretation and industry best practice for position reporting for all market participants.  The asset management industry can directly benefit from the experience of their sell-side counterparties.” said Brock Arnason, Founder and Chief Executive Officer of Droit. “FINBOURNE’s platform, built specifically to support the volume and complexity of data that characterizes position reporting, integrated with our consensus-driven eligibility rules, offers firms unrivaled traceability, transparency, and auditability.”
About Droit
Droit is a technology firm at the forefront of computational law and regulation within finance and other domains. Founded in 2012, Droit counts many of the largest financial institutions as its clients. Its award-winning, patented platform Adept provides an implementation of regulatory rules reflecting industry consensus. The Adept platform processes tens of millions of inquiries a day, deciding in real-time which interactions are legally permissible across the globe. Adept is used by institutions to evaluate, with sub-millisecond latency, the full regulatory implications of any given interaction within their transactional infrastructure.
For more information visit droit.tech. To obtain more information about Droit’s products, please contact [email protected].
About FINBOURNE Technology 
FINBOURNE combines extensive technical expertise in financial services data management with a best-in-class, open, cloud–based investment management and servicing product ecosystem. By deploying our solutions, our clients can better aggregate, manage and utilise data across their organisations.
With operations across North America, Europe, Asia and Australia, FINBOURNE’s data management solutions help financial services firms improve their investment management and servicing capabilities.
FINBOURNE is trusted by some of the world’s leading financial services firms, including Fidelity International, London Stock Exchange Group, Baillie Gifford and Northern Trust. 
For more information on FINBOURNE Technology visit www.FINBOURNE.com or contact [email protected] 
Logo – https://mma.prnewswire.com/media/2016603/Droit_Logo.jpgLogo – https://mma.prnewswire.com/media/2400551/Finbourne_logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/droit-and-finbourne-partner-to-deliver-end-to-end-position-reporting-solution-302130494.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending